FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Clears Implicity Heart Failure Algorithm

FDA clears an Implicity 510(k) for its algorithm SignalHF used in its remote monitoring for heart failure.

latest-news-card-1
Human Drugs

Bipartisan Bill on Clinical Trial Participation

Representatives Raul Ruiz (D-CA) and Larry Bucshon (R-IN) introduce bipartisan legislation to improve participation in clinical trials by underreprese...

latest-news-card-1
Human Drugs

Brainomix Gets Clearance for AI e-Lung Tool

FDA clears a Brainomix 510(k) for its Brainomix 360 e-Lung for lung imaging.

latest-news-card-1
Human Drugs

SCANLY Home Optical Tomography Device Authorized

FDA grants Notal Vision a de novo authorization for its patient self-operated SCANLY Home optical coherence tomography device.

latest-news-card-1
Federal Register

X4 Pharma Gets Priority Review Voucher

Federal Register notice: FDA announces the issuance of a priority review voucher to X4 Pharmaceuticals in response to gaining approval of a rare pedia...

latest-news-card-1
Medical Devices

FDA Qualifies New Ophthalmic Outcome Tool

FDA qualifies the Assessment of IntraOcular Lens Implant Symptoms patient-reported instrument as a medical device development tool.

latest-news-card-1
Human Drugs

Lilly Once-Weekly Insulin Meets Trial Endpoints

Lilly says its once-weekly insulin efsitora alfa met endpoints in two trials with insulin-nave adults with Type 2 diabetes.

latest-news-card-1
Medical Devices

Draeger Anesthesia Device Correction Updated

FDA updates a Draeger Class 1 recall (device correction) of the Perseus A500 anesthesia workstation after receiving reports that the internal backup b...

latest-news-card-1
Biologics

Biogen/Ionis Scrap ALS Drug Development

Biogen and Ionis Pharmaceuticals discontinue the development of BIIB105 (ION541), an investigational antisense oligonucleotide for amyotrophic lateral...

latest-news-card-1
Human Drugs

Drug Nanomaterial Guidance Explained

CDER review chemist Andrei Ponta discusses the recent guidance on nanomaterials in drugs and biologics on a Center small business assistance podcast.